General Information
Revision date
2022-07-22
Product name
ZANTAC INJECTION
Product Synonyms
ZANTAC INJECTION 25 MG/ML * ZANTAC INJECTION 25 MG/ML (NZ) * ZANTAC INJECTION
CAS No.
66357-59-3
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
2.1 Classification of the substance or mixture
The mixture has been assessed and/or tested for its physical, health and environmental hazards and the following classification applies.
EU Classification
Regulation (EC) No 1272/2008 as amended
Health hazards
Skin sensitisation Category 1 H317 - May cause an allergic skin reaction.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended
Contains
RANITIDINE HYDROCHLORIDE
Signal word
Warning
Hazard statements
H317 May cause an allergic skin reaction.
Prevention
P261 Avoid breathing mist/vapours. P272 Contaminated work clothing should not be allowed out of the workplace. P280 Wear protective gloves.
Response
P321 Specific treatment (see instruction on this label). P333 + P313 If skin irritation or rash occurs: Get medical advice/attention. P362 + P364 Take off contaminated clothing and wash it before reuse.
Storage
Not available.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Supplemental label elements
2.5 % of the mixture consists of component(s) of unknown acute dermal toxicity. 2.5 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 2.5 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
